These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32682383)

  • 21. Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway.
    Wang R; Ma L; Weng D; Yao J; Liu X; Jin F
    Oncol Rep; 2016 May; 35(5):3075-83. PubMed ID: 26987028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anlotinib may enhance the efficacy of anti-PD1 therapy by inhibiting the AKT pathway and promoting the apoptosis of CAFs in lung adenocarcinoma.
    Tang H; You T; Ge H; Gao J; Wang Y; Bai C; Sun Z; Han Q; Zhao RC
    Int Immunopharmacol; 2024 May; 133():112053. PubMed ID: 38615380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New application of an old drug: Antitumor activity and mechanisms of doxycycline in small cell lung cancer.
    Wang SQ; Zhao BX; Liu Y; Wang YT; Liang QY; Cai Y; Zhang YQ; Yang JH; Song ZH; Li GF
    Int J Oncol; 2016 Apr; 48(4):1353-60. PubMed ID: 26846275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silencing TRIM29 Sensitizes Non-small Cell Lung Cancer Cells to Anlotinib by Promoting Apoptosis
    Wu M; Jin MM; Cao XH; Zhao L; Li YH
    Curr Cancer Drug Targets; 2024; 24(4):445-454. PubMed ID: 37644752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anlotinib can overcome acquired resistance to EGFR-TKIs via FGFR1 signaling in non-small cell lung cancer without harboring EGFR T790M mutation.
    Lian Z; Du W; Zhang Y; Fu Y; Liu T; Wang A; Cai T; Zhu J; Zeng Y; Liu Z; Huang JA
    Thorac Cancer; 2020 Jul; 11(7):1934-1943. PubMed ID: 32433828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects and Mechanisms of Anlotinib and Dihydroartemisinin Combination Therapy in Ameliorating Malignant Biological Behavior of Gastric Cancer Cells.
    Luo Q; Zhang S; Zhang D; Feng R; Li N; Chen W; Chen X; Yang S
    Curr Pharm Biotechnol; 2021; 22(4):523-533. PubMed ID: 32576126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiproliferative Activity of Carnosic Acid is Mediated via Inhibition of Cell Migration and Invasion, and Suppression of Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
    Zhao L; Zhang J; Fan Y; Li Y
    Med Sci Monit; 2019 Oct; 25():7864-7871. PubMed ID: 31631173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of tumor cavitation in extensive-stage small-cell lung cancer patients treated with anlotinib.
    Chen D; Xu J; Zhao Y; Chu T; Zhong H; Han B; Zhong R
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):401-406. PubMed ID: 31691871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The novel role of etoposide in inhibiting the migration and proliferation of small cell lung cancer and breast cancer via targeting Daam1.
    Yu X; Xu T; Su B; Zhou J; Xu B; Zhang Y; Zhu Y; Jiang N; He Z
    Biochem Pharmacol; 2023 Apr; 210():115468. PubMed ID: 36858182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Foretinib induces G2/M cell cycle arrest, apoptosis, and invasion in human glioblastoma cells through c-MET inhibition.
    Gortany NK; Panahi G; Ghafari H; Shekari M; Ghazi-Khansari M
    Cancer Chemother Pharmacol; 2021 Jun; 87(6):827-842. PubMed ID: 33688998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential Antitumor Activity of SIM-89 in Non-Small Cell Lung Cancer Cells.
    Pei J; Chu T; Shao M; Teng J; Sha H; Gu A; Li R; Qian J; Mao W; Li Y; Han B
    Yonsei Med J; 2017 May; 58(3):581-591. PubMed ID: 28332364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anlotinib Suppresses Oral Squamous Cell Carcinoma Growth and Metastasis by Targeting the RAS Protein to Inhibit the PI3K/Akt Signalling Pathway.
    Lu Y; Lin J; Duan M; Rui Y; Zheng H; Zhu L; Zhu X; Wei J
    Anal Cell Pathol (Amst); 2021; 2021():5228713. PubMed ID: 34926131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect and mechanism of rapamycin on proliferation and apoptosis of human lung cancer cells.
    Cao W; Ma L
    Cell Mol Biol (Noisy-le-grand); 2020 Sep; 66(6):65-70. PubMed ID: 33040787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The human lung cancer drug resistance-related gene BC006151 regulates chemosensitivity in H446/CDDP cells.
    Li S; Shi H; Ji F; Wang B; Feng Q; Feng X; Jia Z; Zhao Q; Qian G
    Biol Pharm Bull; 2010; 33(8):1285-90. PubMed ID: 20686220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of A549 cell proliferation and metastasis by calycosin via inhibition of the PKC‑α/ERK1/2 pathway: An in vitro investigation.
    Cheng XD; Gu JF; Yuan JR; Feng L; Jia XB
    Mol Med Rep; 2015 Dec; 12(6):7992-8002. PubMed ID: 26498639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor effects of 3-bromoascochlorin on small cell lung cancer via inhibiting MAPK pathway.
    Zhang Z; Zhang Y; Yang C; Wang Q; Wang H; Zhang Y; Deng W; Nie Y; Liu Y; Luo X; Huang J; Wang J
    Cell Biol Int; 2021 Nov; 45(11):2380-2390. PubMed ID: 34288235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
    Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
    Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways.
    Wan J; Wu W
    J Exp Clin Cancer Res; 2016 Jul; 35(1):119. PubMed ID: 27456341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salidroside represses proliferation, migration and invasion of human lung cancer cells through AKT and MEK/ERK signal pathway.
    Ren M; Xu W; Xu T
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1014-1021. PubMed ID: 30880481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anlotinib inhibits the proliferation and induces apoptosis by inactivating the AKT pathway in androgen receptor-negative prostate cancer cells.
    Xu Y; Zheng J; Ye ZY
    Neoplasma; 2022 Sep; 69(5):1119-1128. PubMed ID: 36004650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.